Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29801 - 29825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	PKD2	5311	upregulated	decitabine results in increased expression of PKD2 mRNA	4q22.1	A20985
Decitabine	Approved Investigational	PLA2G2A	5320	upregulated	decitabine results in increased expression of PLA2G2A mRNA	1p36.13	A22009 A22010
Decitabine	Approved Investigational	PLA2R1	22925	upregulated	decitabine results in increased expression of PLA2R1 mRNA	2q23-q24	A22010
Decitabine	Approved Investigational	PLAGL1	5325	upregulated	decitabine results in increased expression of PLAGL1 mRNA	6q24.2	A21919
Decitabine	Approved Investigational	PLAU	5328	upregulated	decitabine results in increased expression of PLAU mRNA	10q22.2	A21919 A21845
Decitabine	Approved Investigational	PLIN2	123	upregulated	decitabine results in increased expression of PLIN2 mRNA	9p22.1	A21919
Decitabine	Approved Investigational	PLK2	10769	upregulated	decitabine results in increased expression of PLK2 mRNA	5q11.2	A21978
Decitabine	Approved Investigational	PLP2	5355	upregulated	decitabine results in increased expression of PLP2 mRNA	Xp11.23	A20985
Decitabine	Approved Investigational	PLPP2	8612	upregulated	decitabine results in increased expression of PLPP2 mRNA	19p13.3	A21917
Decitabine	Approved Investigational	PMEPA1	56937	upregulated	decitabine results in increased expression of PMEPA1 mRNA	20q13.31	A21923
Decitabine	Approved Investigational	PMP22	5376	upregulated	decitabine results in increased expression of PMP22 mRNA	17p12	A21930
Decitabine	Approved Investigational	PMS2	5395	upregulated	decitabine results in increased expression of PMS2 mRNA	7p22.1	A21181
Decitabine	Approved Investigational	POLR3E	55718	downregulated	decitabine results in decreased expression of POLR3E mRNA	16p12.2	A20985
Decitabine	Approved Investigational	PPARG	5468	upregulated	decitabine results in increased expression of PPARG mRNA	3p25.2	A22003
Decitabine	Approved Investigational	PPIC	5480	upregulated	decitabine results in increased expression of PPIC mRNA	5q23.2	A21919
Decitabine	Approved Investigational	PPM1D	8493	upregulated	decitabine results in increased expression of PPM1D mRNA	17q23.3	A21978
Decitabine	Approved Investigational	PRDX2	7001	upregulated	decitabine results in increased expression of PRDX2 mRNA	19p13.13	A20985
Decitabine	Approved Investigational	PRDX5	25824	upregulated	decitabine results in increased expression of PRDX5 mRNA	11q13.1	A22002
Decitabine	Approved Investigational	PRG2	5553	upregulated	decitabine results in increased expression of PRG2 mRNA	11q12.1	A20985
Decitabine	Approved Investigational	PRKAG1	5571	upregulated	decitabine results in increased expression of PRKAG1 mRNA	12q13.12	A21917
Decitabine	Approved Investigational	PROX1	5629	upregulated	decitabine results in increased expression of PROX1 mRNA	1q32.3	A22011
Decitabine	Approved Investigational	PSTPIP1	9051	upregulated	decitabine results in increased expression of PSTPIP1 mRNA	15q24.3	A20985
Decitabine	Approved Investigational	PTEN	5728	upregulated	decitabine results in increased expression of PTEN mRNA	10q23.31	A22012 A21623
Decitabine	Approved Investigational	PTPN6	5777	upregulated	decitabine results in increased expression of PTPN6 mRNA	12p13.31	A22013 A22014 A22015 A20849
Decitabine	Approved Investigational	PTPN9	5780	downregulated	decitabine results in decreased expression of PTPN9 mRNA	15q24.2	A21913

Displaying entries 29801 - 29825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability